Isorhamnetin suppresses colon cancer cell growth through the PI3K-Akt-mTOR pathwayChuan Li(Tongji Hospital), Junbo Hu(Tongji Hospital)Molecular Medicine ReportsJanuary 7, 201410.3892/mmr.2014.1886Cited by 98SaveCiteExport RISWatch citationsRelated PapersPRMT5 methylating Smad4 activates TGF-β signaling and promotes colorectal cancer metastasis|Research Square|2022|0